Nuplazid (Q47521918)
Jump to navigation
Jump to search
pharmaceutical product
Language | Label | Description | Also known as |
---|---|---|---|
English | Nuplazid |
pharmaceutical product |
Statements
1 reference
Nuplazid® is the only FDA-approved medicine proven to reduce the frequency and/or severity of hallucinations and delusions related to Parkinson's (English)
8
March 2020
83
4
Identifiers
1 reference